These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1563330)

  • 1. Platelet function in male diabetics with and without macrovascular complications.
    Tóth L; Szénási P; Jámbor G; Kammerer L; Romics L
    Diabetes Res Clin Pract; 1992 Feb; 15(2):143-8. PubMed ID: 1563330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C; Schernthaner G
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet hyper- and hypoaggregability in different microangiopathic complications of diabetes mellitus.
    Szénási P; Tóth L; Romics L; Kammerer L
    Acta Diabetol Lat; 1988; 25(1):7-12. PubMed ID: 3407379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostasis variables in type I diabetic patients without demonstrable vascular complications.
    el Khawand C; Jamart J; Donckier J; Chatelain B; Lavenne E; Moriau M; Buysschaert M
    Diabetes Care; 1993 Aug; 16(8):1137-45. PubMed ID: 8375244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent increase in in vitro platelet sensitivity to adenosine-5'-diphosphate in young complication-free diabetic males.
    Davis TM; Bown EG; Turner RC
    Diabetes Res; 1990 Nov; 15(3):103-7. PubMed ID: 2132201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet reactivity in type 2 diabetes mellitus: a comparative analysis with survivors of myocardial infarction and the role of glycaemic control.
    Mylotte D; Kavanagh GF; Peace AJ; Tedesco AF; Carmody D; O'Reilly M; Foley DP; Thompson CJ; Agha A; Smith D; Kenny D
    Platelets; 2012; 23(6):439-46. PubMed ID: 22150374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased platelet aggregability in diabetic children: relation to serum lipid and fatty acid composition.
    Ewald U; Kobbah M; Vessby B; Tuvemo T
    Diabetologia; 1983 Nov; 25(5):382-5. PubMed ID: 6653942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus.
    Yamada K; Mori K; Goto Y
    Tohoku J Exp Med; 1981 Dec; 135(4):423-9. PubMed ID: 6175049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vitamin E administration on platelet function in diabetes mellitus.
    Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
    Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
    Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
    [No Abstract]   [Full Text] [Related]  

  • 11. Moderate exercise increases platelet function in type I diabetic patients without severe angiopathy and in good control.
    Trovati M; Anfossi G; De Facis R; Mularoni E; Massucco P; Cavalot F; Burzacca S; Mattiello L; Lucchina PG
    Diabetes Care; 1992 Nov; 15(11):1742-6. PubMed ID: 1468311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet aggregation in early diabetus mellitus.
    Sagel J; Colwell JA; Crook L; Laimins M
    Ann Intern Med; 1975 Jun; 82(6):733-8. PubMed ID: 1138583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
    Malyszko J; Urano T; Knofler R; Taminato A; Yoshimi T; Takada Y; Takada A
    Thromb Res; 1994 Sep; 75(5):569-76. PubMed ID: 7992257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid decrease of platelet aggregation (ADP--and collagen--induced) and of platelet circulating aggregates by the artificial pancreas in insulin-dependent diabetics.
    Coppola L; Misso L; Giugliano D; Torella R; Passariello N; Tirelli A
    Diabete Metab; 1984 Jan; 10(1):31-5. PubMed ID: 6724099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus.
    Coppola L; Verrazzo G; La Marca C; Ziccardi P; Grassia A; Tirelli A; Giugliano D
    Diabet Med; 1997 Nov; 14(11):959-63. PubMed ID: 9400920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered platelet function in diabetes mellitus.
    Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
    Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences in platelet aggregation in various microangiopathic complications of diabetes mellitus].
    Szénási P; Tóth L; Kammerer L; Romics L
    Orv Hetil; 1989 Mar; 130(12):617-20. PubMed ID: 2649841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between fatty acid pattern and platelet aggregation in long-term insulin-dependent type I diabetics.
    Schimke E; Hildebrandt R; Grzeskowiak B
    Biomed Biochim Acta; 1988; 47(10-11):S274-7. PubMed ID: 3248113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pioglitazone on platelet aggregation in a healthy cohort.
    Chokesuwattanaskul W; Yaqub Y; Suarez JA; Simoni J; Simoni G; Nugent KM; Jimenez R; Perez-Verdia A
    Cardiology; 2010; 116(4):253-6. PubMed ID: 20798535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal platelet aggregation in chronic symptomatic diabetic peripheral neuropathy.
    Jennings PE; Dallinger KJ; Nightingale S; Barnett AH
    Diabet Med; 1986 May; 3(3):237-40. PubMed ID: 2951176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.